Scientech Research’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Scientech Research's VKTX Position: Q2 2026 in Review
Scientech Research opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 14,456 shares worth $564K. The stake represents 0.46% of the portfolio and ranks #72 among its holdings. This is a return to the name: Scientech Research previously reported a position in VKTX as recently as Q1 2025.
Scientech Research first reported a position in VKTX in Q2 2024 and has held it in 3 quarters since. 438 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.
- Scientech Research held 14,456 shares of Viking Therapeutics worth $564K as of Q2 2026.
- Viking Therapeutics was a new Scientech Research position in Q2 2026.
- Viking Therapeutics made up 0.46% of Scientech Research's portfolio in Q2 2026, its #72 holding.
- Scientech Research first reported a position in Viking Therapeutics in Q2 2024 and has held it in 3 quarters since.
- 438 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.